HanchorBio Presents Preclinical Data on HCB301 at SITC 2025
November 06, 2025 | 11:54
HanchorBio Inc., today announced that the preclinical data on HCB301, has been accepted for presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer, taking place November 5-9, 2025, in National Harbor, Maryland.
Mobile Version